amylyx glp 1 Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation Weight Management Support Powered by Peptide GLP Amylyx nears pivotal readout on
Description
Most are taken via weekly or daily self-injection
In a large clinical trial, adults using Saxenda lost an average of 8% of their starting body weight
This drug mimics the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which helps to regulate blood sugar levels after eating
J Physiol 587(19):47494759 [DOI] [PMC free article] [PubMed] [Google Scholar] Hlscher C (2014) Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
Frequently asked questions When did Weight Watchers stop offering compounded semaglutide
doi:10.1177/1533317514545379 122
